E
Sell
3/20/2025Downgrade
Third Harmonic Bio, Inc. (THRD) was downgraded to E+ from D- on 3/20/2025 due to a decline in the volatility index.
D
Sell
3/5/2025Upgraded
Third Harmonic Bio, Inc. (THRD) was upgraded to D- from E+ on 3/5/2025 due to an increase in the volatility index and valuation index.
E
Sell
2/13/2025Downgrade
Third Harmonic Bio, Inc. (THRD) was downgraded to E+ from D- on 2/13/2025 due to a large decline in the growth index and volatility index. Earnings per share declined from -$0.264 to -$0.334, and EBIT declined 21.34% from -$14.07M to -$17.07M.
D
Sell
9/18/2023Upgraded
Third Harmonic Bio, Inc. (THRD) was upgraded to D- from E+ on 9/18/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
8/11/2023Downgrade
Third Harmonic Bio, Inc. (THRD) was downgraded to E+ from D- on 8/11/2023 due to a substantial decline in the efficiency index and valuation index. Total capital declined 1.68% from $287.11M to $282.29M.
D
Sell
6/2/2023Upgraded
Third Harmonic Bio, Inc. (THRD) was upgraded to D- from E on 6/2/2023 due to a noticeable increase in the growth index, volatility index and solvency index. Operating cash flow increased 28.13% from -$9.29M to -$6.68M, earnings per share increased from -$0.5141 to -$0.3986, and the quick ratio increased from 51.1 to 57.05.
E
Sell
3/1/2023Upgraded
Third Harmonic Bio, Inc. (THRD) was upgraded to E from E- on 3/1/2023 due to an increase in the valuation index.
E
Sell
12/15/2022Downgrade
Third Harmonic Bio, Inc. (THRD) was downgraded to E- from E on 12/15/2022 due to a major decline in the volatility index.
E
Sell
12/8/2022None
Third Harmonic Bio, Inc. (THRD) was downgraded to E from U on 12/08/2022.
